News
Thomson Reuters' Pharma Matters highlights Vaccinogen’s OncoVAX® as “One to Watch”
The Pharma Matters quarterly report series was launched two years ago and covers all aspects of the pharmaceutical pipeline, leveraging strategic intelligence and competitive analysis...
Learn more >>
Vaccinogen's New Anti-Cancer Vaccine Commercially Available in Europe This Year
Vaccinogen, Inc. announced that its new vaccine to block colon
cancer from recurring will be commercially available in Europe starting June 2008...
Learn more >>
Publications
Human Vaccines 2006
Active Specific Immunotherapy with Autologous Tumor Cell Vaccines
Learn more >>
Cancer Vaccine Space
Vaccinogen is uniquely positioned within the cancer vaccine space
Learn more >>